Abstract: Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines reduce the levels of TNF? in a mammal. A typical embodiment is 1-oxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4,5,6,7-tetrafluoroisoindoline.

Abstract: The present invention relates to Diphenylethylene Compounds and compositions comprising a Diphenylethylene Compound. The present invention also relates to methods for preventing or treating various diseases and disorders by administering to a subject in need thereof one or more Diphenylethylene Compounds. In particular, the invention relates to methods for preventing or treating cancer or an inflammatory disorder by administering to a subject in need thereof one or more Diphenylethylene Compounds. The present invention further relates to articles of manufacture and kits comprising one or more Diphenylethylene Compounds.

Abstract: Novel amides and imides are inhibitors of tumor necrosis factor? and phosphodiesterase and can be used to combat cachexia, endotoxic shock, retrovirus replication, asthma, and inflammatory conditions.

Abstract: Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione are disclosed. Compositions comprising the polymorphic forms, methods of making the polymorphic forms and methods of their use are also disclosed.

Abstract: Novel imides are inhibitors of tumor necrosis factor alpha and can be used to combat cachexia, endotoxic shock, and retrovirus replication. A typical embodiment is (R)-2-Phthalimido-3-(3?,4?-dimethoxyphenyl)propane.

Abstract: The present invention relates to Diphenylethylene Compounds and compositions comprising a Diphenylethylene Compound. The present invention also relates to methods for preventing or treating various diseases and disorders by administering to a subject in need thereof one or more Diphenylethylene Compounds. In particular, the invention relates to methods for preventing or treating cancer or an inflammatory disorder by administering to a subject in need thereof one or more Diphenylethylene Compounds. The present invention further relates to articles of manufacture and kits comprising one or more Diphenylethylene Compounds.

Abstract: Isoindolin-1-one and Isoindoline-1,3-dione substituted in the 2-position with a 2,6-dioxo-3-hydroxypiperidin-5-yl group, which may be further substituted in the 5-position with alkyl or halogeno, and in the 4-position with alkyl or a nitrogen-containing group are inhibitors of, and thus useful in the treatment of disease states mediated by, TNF&agr;. A typical embodiment is 2-(2,6-dioxo-3-hydroxy-5-fluoro-piperidin-5-yl)-4-aminoisoindolin-1-one.

Abstract: Isoindolin-1-one and Isoindoline-1,3-dione substituted in the 2-position with a 2,6-dioxo-3-hydroxypiperidin-5-yl group, which may be further substituted in the 5-position with alkyl or halogeno, and in the 4-position with alkyl or a nitrogen-containing group are inhibitors of, and thus useful in the treatment of disease states mediated by, TNF&agr;. A typical embodiment is 2-(2,6-dioxo-3-hydroxy-5-fluoro-piperidin-5-yl)-4-aminoisoindolin-1-one.

Abstract: The present invention provides new methods for inhibiting the activity of the enzyme cycloxygenase-2 (or COX-2). Inhibitors of COX-2 are known to be useful anti-inflammatory, analgesic and anti-angiogenic agents. The compounds in the present case are heterocyclic substituted 4-aminoglutarimides. Methods of using the compounds to inhibit prostaglandin synthesis are claimed.

Abstract: Isoindolin-1-one and Isoindoline-1,3-dione substituted in the 2-position with a 2,6-dioxo-3-hydroxypiperidin-5-yl group, which may be further substituted in the 5-position with alkyl or halogeno, and in the 4-position with alkyl or a nitrogen-containing group are inhibitors of, and thus useful in the treatment of disease states mediated by, TNF&agr;. A typical embodiment is 2-(2,6-dioxo-3-hydroxy-5-fluoro-piperidin-5-yl)-4-aminoisoindolin-1-one.

Abstract: Isoindolin-1-one and Isoindoline-1,3-dione substituted in the 2-position with a 2,6-dioxo-3-hydroxypiperidin-5-yl group, which may be further substituted in the 5-position with alkyl or halogeno, and in the 4-position with alkyl or a nitrogen-containing group are inhibitors of, and thus useful in the treatment of disease states mediated by, TNF&agr;. A typical embodiment is 2-(2,6-dioxo-3-hydroxy-5-fluoropiperidin-5-yl)-4-aminoisoindolin-1-one.

Abstract: An integrated position and direction system is disclosed that includes a digital compass, wherein the digital compass includes at least three sensors, and a satellite positioning system (SATPOS) having a receiver adapted to receive satellite position determining signals. Direction is determined using the digital compass and heading is determined using the SATPOS. At a first location, the integrated position and direction system is oriented to the offset feature and is operated to determine a first set of measurements relative to the offset feature using the digital compass and the satellite positioning system. At a second location, the integrated position and direction system is oriented to the offset feature and is operated to determine a second set of measurements relative to the offset feature using the digital compass and the satellite positioning system. The integrated position and direction system calculates the position of the offset feature using the first and second sets of measurements.

Abstract: The present invention provides new methods for inhibiting the activity of the enzyme cycloxygenase-2 (or COX-2). Inhibitors of COX-2 are know to be useful anti-inflammatory, analgesic and anti-angiogenic agents. The compounds in the present case are heterocyclic substituted 4-aminoglutarimides. Methods of using the compounds to inhibit prostaglandin synthesis are claimed.

Abstract: Imido and amido substituted alkanohydroxamic acids reduce the levels of TNF&agr; and inhibit phosphodiesterase in a mammal. A typical embodiment is 3-(3-cyclopentyloxy-4-methoxyphenyl)-N-hydroxy-3-phthalimidopropionamide.

Abstract: A composition is provided which comprises an acrylamide-containing polymer comprising repeat units derived from at least two monomers, a polypropylene glycol, and optionally, a polysaccharide. Also provided is a water-based composition which can be used as drilling fluid wherein the composition comprises calcium chloride, an acrylamide-containing polymer which has repeat units derived from at least two monomers, a polypropylene glycol, and optionally, a polysaccharide.

Abstract: A composition is provided which comprises an acrylamide-containing polymer comprising repeat units derived from at least two monomers, a polypropylene glycol, and optionally, a polysaccharide. Also provided is a water-based composition which can be used as drilling fluid wherein the composition comprises calcium chloride, an acrylamide-containing polymer which has repeat units derived from at least two monomers, a polypropylene glycol, and optionally, a polysaccharide.

Abstract: N-(sulfomethyl)-N'-arylureas inhibit or suppress bitter and sweet tastes when mixed with sweet and/or bitter tasting compositions, such as foods, beverages and pharmaceutical preparations.

Abstract: N-(sulfomethyl)-N'-arylureas inhibit or suppress bitter and sweet tastes when mixed with sweet and/or bitter tasting compositions, such as foods, beverages and pharmaceutical preparations.

Abstract: A holographic display module is incorporated into a machine with independently operating subsystems, and used to provide an indication of the status or location of the machine subsystems. In one embodiment, a xerographic copier incorporates a holographic display incorporating an outline of the machine. A liquid crystal panel is aligned with the holographic display and selectively addressed in conjunction with signals from the copier subsystems. An illumination subsystem is optimized to provide diffuse illumination of the display.

Abstract: For a copier with a dual mode document handling system for handling both computer forms web (CF) and individual document sheets, there is provided a plural mode integral unit system easily mountable to an end of the copier for handling the input and/or output of both types of documents and providing improved work space. The system includes a first document stacking tray providing both an operator work space and a tray for individual sheets fed to or from the copier document feeder, and also defining a CF guide aperture therein for CF document feeding to or from the document feeder. The system also includes an integral second document stacking tray for properly supporting a fan-folded stack of CF in a operating position. This second tray is pivotally mounted to the first tray and compactly closable thereunder without interfering with the operation of the first tray to provide an attractive and compact closed unit.